Coletiva de imprensa: anúncios do Governo SP - 14/12/2020
Date:
14/12/2020
O Governador João Doria confirmou nesta segunda-feira (14) que o estudo clínico conclusivo da vacina do Instituto Butantan contra o coronavírus será divulgado no dia 23 de dezembro. A medida dá mais agilidade aos trâmites de certificação na Anvisa (Agência Nacional de Vigilância Sanitária) e demais órgãos internacionais de saúde.
“Os brasileiros querem agilidade, querem as vacinas ...
See more details
Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Betacoronavirus/immunology, Epidemiological Monitoring, Immunization Programs/organization & administration, Brazilian Health Surveillance Agency, Clinical Trial, Phase III, Viral Vaccines/supply & distribution, Viral Vaccines/immunology, Healthy Volunteers, Governmental Research Institutes, Risk Groups, Police/organization & administration, Hospital Bed Capacity/statistics & numerical data, Intensive Care Units/statistics & numerical data, Pandemics/statistics & numerical data, Social Isolation, Masks, COVID-19, Plano São Paulo, Coronavac, Instituto Butantan, Sinovac Biotech
Coletiva de imprensa: avanços importantes nos testes clínicos da fase 3 da Coronavac
Date:
23/11/2020
O Governo de São Paulo e o Instituto Butantan confirmaram nesta segunda-feira (23) que o estudo clínico da CoronaVac chegou à fase final e os resultados sairão já na primeira semana de dezembro. A previsão é que 46 milhões de doses estejam disponíveis no Brasil até janeiro de 2021.
Isso será possível porque o estudo clínico alcançou o patamar necessário para abertura da pesquisa e a...
See more details
Pneumonia, Viral/prevention & control, Coronavirus Infections/prevention & control, Pandemics/prevention & control, Betacoronavirus/immunology, Viral Vaccines/immunology, Governmental Research Institutes, Clinical Trial, Phase III, Healthy Volunteers, Epidemiological Monitoring, Hospital Bed Capacity/statistics & numerical data, Local Health Systems/organization & administration, Brazilian Health Surveillance Agency, Mass Vaccination, Intensive Care Units/statistics & numerical data, Coronavirus Infections/diagnosis, Pneumonia, Viral/diagnosis, COVID-19, Plano São Paulo, Instituto Butantan, Coronavac, Sinovac Biotech, Gorinchteyn, Jean
Ministério da Saúde atualiza informações sobre o coronavírus
Date:
19/11/2020
Siga o Ministério da Saúde
http://www.twitter.com/minsaude
http://www.facebook.com/minsaude
http://www.instagram.com/minsaude
https://www.linkedin.com/company/mini...
See more details
Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Pandemics/economics, Viral Vaccines/economics, Local Health Systems/economics, Financial Resources in Health/economics, Betacoronavirus/immunology, Brazil/epidemiology, Ventilators, Mechanical/supply & distribution, Hospital Bed Capacity/statistics & numerical data, Intensive Care Units/statistics & numerical data, Personal Protective Equipment/supply & distribution, Polymerase Chain Reaction/statistics & numerical data, Enzyme-Linked Immunosorbent Assay/statistics & numerical data, Coronavirus Infections/diagnosis, Pneumonia, Viral/diagnosis, Primary Health Care/organization & administration, Noncommunicable Diseases/prevention & control, Health Management, Dental Care/standards, Maternal and Child Health, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Clinical Trial Protocol, Risk Groups, Healthy Volunteers, Mass Vaccination, COVID-19
Coletiva de imprensa: anúncios do Governo SP - 12/11/2020
Date:
12/11/2020
O Governador João Doria anunciou nesta quinta-feira (12) a assinatura de contrato para revitalização da antiga Usina da Traição, firmado entre a Empresa Metropolitana de Águas e Energia S.A. (EMAE) e o consórcio Usina São Paulo SPE S.A.
O grupo venceu a licitação realizada em setembro e será responsável por implementar espaços de uso público na área de 29.804 metros quadrados, inclu...
See more details
Betacoronavirus/immunology, Coronavirus Infections/epidemiology, Coronavirus Infections/immunology, Coronavirus Infections/prevention & control, Pneumonia, Viral/epidemiology, Pneumonia, Viral/immunology, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Epidemiological Monitoring, Local Health Systems/organization & administration, Hospital Bed Capacity/statistics & numerical data, Intensive Care Units/statistics & numerical data, Brazilian Health Surveillance Agency, Viral Vaccines/supply & distribution, Viral Vaccines/immunology, Clinical Trial, Phase III, Environment, Environmental Restoration and Remediation, Healthy Volunteers, COVID-19, Plano São Paulo, Doria, João, Coronavac, Instituto Butantan, Sinovac Biotech, Novo Rio Pinheiros , Empresa Metropolitana de Águas e Energia S.A., Usina São Paulo SPE S.A
Coletiva de imprensa: anúncios do Governo SP - 05/11/2020
Date:
05/11/2020
Saiba mais em: www.saopaulo.sp.gov.br/coronavirus
See more details
Betacoronavirus/immunology, Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Pandemics/prevention & control, Epidemiological Monitoring, Local Health Systems/organization & administration, Intensive Care Units/statistics & numerical data, Hospital Bed Capacity/statistics & numerical data, Quarantine/organization & administration, Masks, Social Isolation, Schools/statistics & numerical data, Organizations/statistics & numerical data, Police, Viral Vaccines/immunology, Healthy Volunteers, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Clinical Trial, Phase III, Vaccine Potency, COVID-19, Plano São Paulo, Doria, João, Instituto Butantan, Coronavac, Sinovac Biotech
Coletiva de imprensa: anúncios do Governo SP - 23/10/2020
Date:
23/10/2020
O Governador João Doria confirmou a criação de seis novos centros de pesquisa científica para testagem e desenvolvimento da CoronaVac, que está em fase final dos estudos clínicos de segurança e eficácia contra o coronavírus. O anúncio foi feito nesta sexta-feira (23), durante entrevista coletiva no Palácio dos Bandeirantes.
“A vacina, que é o tema do momento, é a proteção à vida ...
See more details
Betacoronavirus/immunology, Coronavirus Infections/epidemiology, Coronavirus Infections/immunology, Coronavirus Infections/diagnosis, Pneumonia, Viral/epidemiology, Pneumonia, Viral/diagnosis, Pneumonia, Viral/immunology, Epidemiological Monitoring, Governmental Research Institutes, Pandemics/prevention & control, Local Health Systems/organization & administration, Hospital Bed Capacity/statistics & numerical data, Intensive Care Units/statistics & numerical data, Viral Vaccines/immunology, Quarantine/organization & administration, Clinical Trial, Phase III, Vaccine Potency, Healthy Volunteers, Plano São Paulo, Doria, João, COVID-19, Coronavac, Instituto Butantan, Sinovac Biotech, Instituto de Infectologia Emílio Ribas, Maia, Rodrigo
Coletiva de imprensa: anúncios do Governo SP - 26/10/2020
Date:
26/10/2020
O Governador João Doria anunciou nesta segunda-feira (26) o primeiro Mutirão de Qualificação, com a oferta de mais de 240 mil vagas em cursos gratuitos dos programas Via Rápida, Novotec, São Paulo Criativo, SP Tech e Empreenda Rápido. Os cursos virtuais, remotos e presenciais estarão disponíveis nos 645 municípios do estado. O anúncio faz parte do Retomada 21/22, plano anunciado dia 16 ...
See more details
Betacoronavirus/immunology, Coronavirus Infections/epidemiology, Coronavirus Infections/diagnosis, Pneumonia, Viral/epidemiology, Pneumonia, Viral/diagnosis, Epidemiological Monitoring, Pandemics/prevention & control, Local Health Systems/organization & administration, Hospital Bed Capacity/statistics & numerical data, Intensive Care Units/statistics & numerical data, Quarantine/organization & administration, Credentialing, Masks, Social Isolation, Viral Vaccines/adverse effects, Healthy Volunteers, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Clinical Trial, Phase III, Viral Vaccines/supply & distribution, Plano São Paulo, Doria, João, COVID-19, Instituto Butantan, Coronavac, Sinovac Biotech
Coletiva de imprensa: anúncios do Governo SP - 19/10/2020
Date:
19/10/2020
O Governador João Doria anunciou nesta segunda-feira (19) que a vacina contra o coronavírus em desenvolvimento pelo Instituto Butantan é a mais segura em fase final de testes no Brasil. Estudos clínicos com 9 mil voluntários com idade entre 18 e 59 anos no país mostram que apenas 35% tiveram reações adversas leves após a aplicação, como dor no local da aplicação ou dor de cabeça. Nã...
See more details
Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Pandemics/statistics & numerical data, Epidemiological Monitoring, Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Viral Vaccines/immunology, Hospital Bed Capacity/statistics & numerical data, Intensive Care Units/statistics & numerical data, Pandemics/prevention & control, Healthy Volunteers, Clinical Trial, Phase III, Vaccine Potency, Governmental Research Institutes, Brazilian Health Surveillance Agency, Public Sector/economics, Railroads/economics, Public-Private Sector Partnerships/economics, Doria, João, Plano São Paulo, COVID-19, Sinovac Biotech, Coronavac, Instituto Butantan
Ministério da Saúde atualiza informações sobre o combate à COVID-19 - 15.10.2020
Date:
15/10/2020
Siga o Ministério da Saúde
http://www.twitter.com/minsaude
http://www.facebook.com/minsaude
http://www.instagram.com/minsaude
https://www.linkedin.com/company/mini...
See more details
Betacoronavirus/immunology, Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Pandemics/statistics & numerical data, Intensive Care Units/statistics & numerical data, Hospital Bed Capacity/statistics & numerical data, Epidemiological Monitoring, Financial Resources in Health/economics, Ventilators, Mechanical/supply & distribution, Local Health Systems/organization & administration, Brazil/epidemiology, Coronavirus Infections/diagnosis, Schools, Primary Health Care/organization & administration, Personal Protective Equipment/supply & distribution, Chloroquine/supply & distribution, Hydroxychloroquine/supply & distribution, Oseltamivir/supply & distribution, Hypnotics and Sedatives/supply & distribution, Intubation, Drug Storage, Viral Vaccines/supply & distribution, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Clinical Trial, Phase III, Healthy Volunteers, Governmental Research Institutes, Academies and Institutes, COVID-19, Coronavac, Vacina de Oxford, Pfizer, Jassen, Astrazeneca, Sinovac Biotech, Instituto Butantan, Biontech, Wyeth, Covax
Coletiva de imprensa: anúncios do Governo SP - 30/09/2020
Date:
30/09/2020
O Governador João Doria assinou nesta quarta-feira (30) o termo de compromisso com a biofarmacêutica Sinovac Life Science para fornecimento de 46 milhões de doses da Coronavac ao estado de São Paulo até dezembro de 2020. O potencial imunizante contra o coronavírus é desenvolvido em parceria com o Instituto Butantan.
“São Paulo não perde tempo, São Paulo quer proteger a saúde e a vida ...
See more details
Viral Vaccines/supply & distribution, Viral Vaccines/immunology, Pandemics/prevention & control, Clinical Trial, Phase III, Coronavirus Infections/immunology, Coronavirus Infections/epidemiology, Coronavirus Infections/prevention & control, Pneumonia, Viral/epidemiology, Pneumonia, Viral/prevention & control, Pneumonia, Viral/immunology, Epidemiological Monitoring, Governmental Research Institutes, Public-Private Sector Partnerships/organization & administration, Brazilian Health Surveillance Agency, Risk Groups, Vaccine Potency, Healthy Volunteers, Betacoronavirus/immunology, Local Health Systems/organization & administration, Pandemics/statistics & numerical data, Hospital Bed Capacity/statistics & numerical data, Intensive Care Units/statistics & numerical data, Social Isolation, Quarantine/organization & administration, Vulnerable Populations, Hospitals, Public/supply & distribution, Plano São Paulo, COVID-19, Doria, João, Coronavac, Instituto Butantan, Sinovac Biotech, Hospitais de camapnha
